Sartorius Aktiengesellschaft (SARTF)
OTCMKTS
· Delayed Price · Currency is USD
208.18
+4.42 (2.17%)
At close: May 20, 2025
SARTF Revenue
Sartorius Aktiengesellschaft had revenue of 883.00M EUR in the quarter ending March 31, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 3.44B, up 3.99% year-over-year. In the year 2024, Sartorius Aktiengesellschaft had annual revenue of 3.38B, down -0.44%.
Revenue (ttm)
3.44B EUR
Revenue Growth
+3.99%
P/S Ratio
4.21
Revenue / Employee
254.59K EUR
Employees
13,528
Market Cap
15.66B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.38B | -15.00M | -0.44% |
Dec 31, 2023 | 3.40B | -779.00M | -18.66% |
Dec 31, 2022 | 4.17B | 725.50M | 21.03% |
Dec 31, 2021 | 3.45B | 1.11B | 47.68% |
Dec 31, 2020 | 2.34B | 508.69M | 27.84% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
Sartorius Aktiengesellschaft News
- 5 weeks ago - Sartorius Aktiengesellschaft (SARTF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Sartorius sends U.S. peers higher after Q1 2025 results - Seeking Alpha
- 5 weeks ago - Sartorius AG (SARTF) Reports Strong Q1 Growth and Financial Improvements - GuruFocus
- 5 weeks ago - Sartorius Aktiengesellschaft Non-GAAP EPS of €1.23, revenue of €883M; initiates FY25 outlook - Seeking Alpha
- 2 months ago - Sartorius: Debt, Uncertainty, And Stock Plunge - Is It Still Overvalued? - Seeking Alpha
- 4 months ago - Sartorius Aktiengesellschaft (SARTF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Sartorius lifts U.S. peers after 2024 results - Seeking Alpha
- 4 months ago - Sartorius Aktiengesellschaft Non-GAAP EPS of €4.05, revenue of €3.38B; initiates FY25 soft outlook - Seeking Alpha